BiotechTube
Home/Intezyne/Kevin Sill, Ph.D.
KS

Kevin Sill, Ph.D.

Co-Founder and former CEO/CSO (historical leadership)

Intezyne

Therapeutic Areas

Oncology

Intezyne Pipeline

DrugIndicationPhase
IT-141 (Etoposide IVECT™)Advanced Solid TumorsPhase 1